Robert Ferrell
9Patents
2h-index
14Co-inventors
44Inventor score
Filing activity: Aug 16, 1999 → Sep 23, 2011
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6764820B2 | Screening for lymphatic disorders involving the FLT4 receptor tyrosine kinase (VEGFR-3) | Chemistry; Metallurgy | 4 | Expired |
| US7695909B2 | Susceptibility genes for age-related maculopathy (ARM) on chromosome 10q26 | Chemistry; Metallurgy | 3 | Active |
| US7829536B2 | Method of treating lymphedema comprising administering VEGF-D | Chemistry; Metallurgy | 2 | Active |
| US6399306B1 | Genetic markers which identify individuals who decrease their blood pressure through exercise | Chemistry; Metallurgy | 2 | Expired |
| US8053190B2 | Susceptibility genes for age-related maculopathy (ARM) on chromosome 10q26 | Chemistry; Metallurgy | 1 | Active |
| US6468789B1 | Oxygen sensing and hypoxic selection for tumors | Chemistry; Metallurgy | 1 | Expired |
| US6743587B2 | ACE genotype which correlates with improved success in sodium excretion in hypertensives with exercise | Chemistry; Metallurgy | 0 | Expired |
| US8357669B2 | Method of treatment for lymphedema comprising administering a polynucleotide encoding VEGF-D | Chemistry; Metallurgy | 0 | Active |
| US9260754B2 | Connexin mutation detection for lymphatic variation and disease | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.